Risk of severe COVID-19 outcomes associated with atopic eczema and dupilumab
Risk of severe COVID-19 outcomes associated with atopic eczema and dupilumab is an OpenSAFELY project from The London School of Hygiene & Tropical Medicine. Every time a researcher runs their analytic code against patient data, it is audited in public here.
Project Completed - paper/report linked
This project created no results and may not go ahead due to funding reasons.
Workspaces
-
No workspaces
This project does not have any associated workspaces
Project timeline
-
Project created:
-
Code first run: No code has run
Reports
Recently published reports
-
No reports
This project does not currently have any published reports